FCBT
TECH icon

First Citizens Bank & Trust’s Bio-Techne TECH Stock Holding History

First Citizens Bank & Trust’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$320K Sell
4,529
-850
-16% -$45.9K ﹤0.01% 544
2026
Q1 		$281K Buy
5,379
+255
+5% +$15.3K 0.01% 564
2025
Q4 		$301K Sell
5,124
-1,189
-19% -$72.2K 0.01% 551
2025
Q3 		$351K Sell
6,313
-2,071
-25% -$111K 0.01% 507
2025
Q2 		$431K Sell
8,384
-4,691
-36% -$236K 0.01% 466
2025
Q1 		$767K Sell
13,075
-109,938
-89% -$7.45M 0.02% 264
2024
Q4 		$8.86M Buy
123,013
+120,275
+4,393% +$8.83M 0.16% 67
2024
Q3 		$219K Sell
2,738
-2,340
-46% -$176K ﹤0.01% 436
2024
Q2 		$364K Sell
5,078
-1,433
-22% -$105K 0.01% 348
2024
Q1 		$458K Buy
+6,511
New +$466K 0.01% 324
2013
Q4 		– Sell
-13,880
Closed -$278K – 747
2013
Q3 		$278K Buy
13,880
+292
+2% +$5.54K 0.01% 944
2013
Q2 		$235K Buy
+13,588
New +$226K 0.01% 950

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First Citizens Bank & Trust's TECH Position: Q2 2026 in Review

First Citizens Bank & Trust reduced its Bio-Techne (TECH) stake by 16% in Q2 2026, selling an estimated $45.9K and leaving 4,529 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #544.

First Citizens Bank & Trust first reported a position in TECH in Q2 2013 and has held it in 12 quarters since. The position peaked at $8.86M in Q4 2024. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • First Citizens Bank & Trust held 4,529 shares of Bio-Techne worth $320K as of Q2 2026.
  • First Citizens Bank & Trust sold 850 Bio-Techne shares in Q2 2026, an estimated $45.9K.
  • Bio-Techne made up ﹤0.01% of First Citizens Bank & Trust's portfolio in Q2 2026, its #544 holding.
  • First Citizens Bank & Trust first reported a position in Bio-Techne in Q2 2013 and has held it in 12 quarters since.
  • First Citizens Bank & Trust's Bio-Techne position peaked at $8.86M in Q4 2024.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.